Sentieon Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$20M
- Investors
-
12
Sentieon General Information
Description
Developer of bioinformatics software tools designed to process genomics data with high accuracy and high computing efficiency. The company's products are used for germline variant detection, tumor-normal somatic mutation detection, and comprehensive tumor characterization, enabling scientists, clinicians, and patients to benefit from precision data and computing efficiency, fast turnaround time, accuracy, and consistency.
Contact Information
Website
www.sentieon.comCorporate Office
- 160 East Tasman Drive
- Suite 208
- San Jose, CA 95134
- United States
Corporate Office
- 160 East Tasman Drive
- Suite 208
- San Jose, CA 95134
- United States
Sentieon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 30-Sep-2015 | $20M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 12-Sep-2014 | Completed | Startup |
Sentieon Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Sentieon Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sentieon Patents
Sentieon Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160283654-A1 | Computation pipeline of single-pass multiple variant calls | Active | 27-Mar-2015 | ||
| US-20160283655-A1 | Computation pipeline of location-dependent variant calls | Active | 27-Mar-2015 | ||
| US-10424395-B2 | Computation pipeline of single-pass multiple variant calls | Active | 27-Mar-2015 | ||
| US-10424396-B2 | Computation pipeline of location-dependent variant calls | Active | 27-Mar-2015 | G16B30/00 |
Sentieon Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sentieon Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3E Bioventures (China) | Venture Capital | Minority | ||
| Amino Capital | Venture Capital | Minority | ||
| CLI Ventures | Venture Capital | Minority | ||
| GRC SinoGreen Fund | Venture Capital | Minority | ||
| IDG Capital | Venture Capital | Minority |
Sentieon FAQs
-
When was Sentieon founded?
Sentieon was founded in 2014.
-
Where is Sentieon headquartered?
Sentieon is headquartered in San Jose, CA.
-
What is the size of Sentieon?
Sentieon has 14 total employees.
-
What industry is Sentieon in?
Sentieon’s primary industry is Other Healthcare Technology Systems.
-
Is Sentieon a private or public company?
Sentieon is a Private company.
-
What is the current valuation of Sentieon?
The current valuation of Sentieon is .
-
What is Sentieon’s current revenue?
The current revenue for Sentieon is .
-
How much funding has Sentieon raised over time?
Sentieon has raised $23.8M.
-
Who are Sentieon’s investors?
3E Bioventures (China), Amino Capital, CLI Ventures, GRC SinoGreen Fund, and IDG Capital are 5 of 12 investors who have invested in Sentieon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
